Renasant Corporation

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong FCF
  • Low asset turnover
  • Large deposit base

AI
AI Summary

6.0

Renasant is now an execution‑centric investment: the stock can re-rate toward tangible‑book value only if management delivers quantified post‑merger cost synergies, stabilizes deposits, and prevents sector‑specific credit deterioration (multifamily, senior housing, self‑storage, C&I); failure to do so will keep ROE depressed and justify the sub‑1x price/book multiple.

SynergyWin
ExecutionRisk
AssetQuality‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong FCF
  • Low asset turnover
  • Large deposit base

RNST generates strong free cash flow and healthy margins but is hampered by very low asset turnover and large deposit‑centric liabilities that compress returns.

CashFlow
CapitalInefficiency

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Below average
  • Near short-term support

RNST is in a clear short-term downtrend—about 6% below its last-month average (~$37.07) with immediate support near $34.39 and resistance $37.0–$38.5, remaining bearish unless it reclaims and holds above the last-month average.

bearish
monitor
Support Level: $34.39; mid-$35s
Resistance Level: $37.0–$38.5; last-month avg ~$37.07

Drop from $40.23 to $34.81 over the last month signals clear short-term weakness

Sentiment & News

6.0

Key News Insights:

  • Comparative scrutiny
  • Institutional stake
  • Dividend attention

Renasant is drawing analyst comparisons against regional peers on fundamentals and shareholder metrics while a large Channing Capital stake signals rising institutional interest.

InstitutionalBuy
PeerBenchmark

Continued peer benchmarking plus notable institutional buying should support investor focus on RNST's relative valuation and could boost demand if fundamentals remain steady